MCID: CLR017
MIFTS: 46

Clear Cell Sarcoma malady

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Clear Cell Sarcoma

Aliases & Descriptions for Clear Cell Sarcoma:

Name: Clear Cell Sarcoma 12 14
Sarcoma, Clear Cell 42 69
Adult Soft Part Clear Cell Sarcoma 12
Malignant Melanoma of Soft Tissues 12
Melanoma, Malignant, of Soft Parts 12
Clear Cell Sarcoma of Soft Parts 12
Malignant Melanoma of Soft Parts 12
Sarcoma Clear Cell 52

Classifications:



External Ids:

Disease Ontology 12 DOID:4233
MeSH 42 D018227
NCIt 47 C27370 C3745

Summaries for Clear Cell Sarcoma

Disease Ontology : 12 A sarcoma that is characterized by solid nests and fascicles of tumor cells with clear cytoplasm and prominent nucleoli. It presents as a slow growing mass that especially affects tendons and aponeuroses and it is deeply situated.

MalaCards based summary : Clear Cell Sarcoma, also known as sarcoma, clear cell, is related to liposarcoma and kidney clear cell sarcoma. An important gene associated with Clear Cell Sarcoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Activation of cAMP-Dependent PKA and MAPK-Erk Pathway. The drugs Carboplatin and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and lymph node, and related phenotypes are cardiovascular system and embryo

Wikipedia : 71 Clear-cell sarcoma (formerly known as malignant melanoma of the soft parts) is a rare form of cancer... more...

Related Diseases for Clear Cell Sarcoma

Diseases in the Small Cell Sarcoma family:

Clear Cell Sarcoma

Diseases related to Clear Cell Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 89)
id Related Disease Score Top Affiliating Genes
1 liposarcoma 29.8 EWSR1 WT1
2 kidney clear cell sarcoma 12.4
3 melanoma of soft tissue 11.7
4 sarcoma 11.0
5 melanoma 10.6
6 hydrarthrosis 10.3 BCOR YWHAE
7 multiple spinal canal and spinal cord meningioma 10.2 ATF1 WT1
8 leukoencephalopathy palmoplantar keratoderma 10.2 MITF S100B
9 endocardium cancer 10.2 EWSR1 S100B
10 invasive mole 10.2 KIT S100B
11 corneal intraepithelial neoplasm 10.2 S100B WT1
12 gliofibroma 10.2 EWSR1 WT1
13 intracranial embolism 10.2 MITF WT1
14 glomus tumor 10.2 KIT MITF
15 plexopathy 10.2 EWSR1 WT1
16 monkeypox 10.2 KIT S100B
17 choriocarcinoma 10.2 KIT WT1
18 foix-alajouanine syndrome 10.2 FUS S100B
19 kahrizi syndrome 10.2 KIT WT1
20 liver angiosarcoma 10.1 KIT WT1
21 verrucous papilloma 10.1 KIT MITF
22 ovarian large-cell neuroendocrine carcinoma 10.1 EWSR1 FUS
23 diabetes persistent mullerian ducts 10.1 EWSR1 S100B WT1
24 precursor t-lymphoblastic lymphoma/leukemia 10.1 KIT S100B
25 vulval paget's disease 10.1 ATF1 KIT
26 rete ovarii neoplasm 10.1 BCOR WT1 YWHAE
27 bilateral multicystic dysplastic kidney 10.1 ATF1 CREB1 EWSR1
28 stickler syndrome, type i 10.1 ATF1 EWSR1 FUS
29 peripheral osteosarcoma 10.1 EWSR1 WT1
30 extraosseous ewing's sarcoma 10.1 BCOR KIT YWHAE
31 gastric leiomyosarcoma 10.1 IGF2 KIT
32 prostate leiomyosarcoma 10.1 IGF2 KIT
33 transverse colon cancer 10.1 EWSR1 FUS
34 malignant pleural solitary fibrous tumor 10.1 EWSR1 KIT MITF
35 morbid obesity 10.1 ATF1 CREB1
36 colorectal cancer 1 10.1 EWSR1 FUS WT1
37 uterine hypoplasia 10.0 IGF2 KIT
38 thyroid carcinoma, papillary, with papillary renal neoplasia 10.0 KIT MITF WT1
39 pediatric germ cell cancer 10.0 KIT MITF S100B
40 stomach diverticulosis 10.0 KIT S100B
41 larynx leiomyosarcoma 10.0 IGF2 KIT
42 hemorrhagic fever 10.0 IGF2 WT1
43 diarrhea, chronic, with villous atrophy 10.0 IGF2 KIT S100B
44 diffuse glomerulonephritis 9.9 IGF2 KIT WT1
45 hypohidrosis 9.9 ATF1 EWSR1 FUS KIT
46 gestational choriocarcinoma 9.9 EWSR1 FUS KIT WT1
47 mediastinum sarcoma 9.8 EWSR1 IGF2 KIT WT1
48 adenosarcoma 9.8 IGF2 KIT S100B WT1
49 alveolar soft-part sarcoma 9.8
50 tendinitis 9.8

Graphical network of the top 20 diseases related to Clear Cell Sarcoma:



Diseases related to Clear Cell Sarcoma

Symptoms & Phenotypes for Clear Cell Sarcoma

MGI Mouse Phenotypes related to Clear Cell Sarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.7 BCOR CREB1 ERBB3 IGF2 KIT WT1
2 embryo MP:0005380 9.5 WT1 BCOR CREB1 ERBB3 IGF2 KIT
3 muscle MP:0005369 9.1 CREB1 ERBB3 IGF2 KIT WT1 YWHAE

Drugs & Therapeutics for Clear Cell Sarcoma

Drugs for Clear Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 141)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
3
Dactinomycin Approved Phase 3,Phase 2 50-76-0 2019 457193
4
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
5
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
6
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
7
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
8
Sulfamethoxazole Approved Phase 3 723-46-6 5329
9
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
10
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
11
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
13
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
14
Morphine Approved, Investigational Phase 3 57-27-2 5288826
15
Cyproheptadine Approved Phase 3 129-03-3 2913
16
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
17
Doxil Approved June 1999 Phase 3,Phase 2 31703
18 Alkylating Agents Phase 3,Phase 2,Phase 1
19 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
20 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
21 Anti-Infective Agents Phase 3,Phase 2,Phase 1
22 Antimitotic Agents Phase 3,Phase 2,Phase 1
23 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
24 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
25 Antirheumatic Agents Phase 3,Phase 2,Phase 1
26 Etoposide phosphate Phase 3,Phase 2,Phase 1
27 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
28 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
29 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
30 Adjuvants, Immunologic Phase 3,Phase 2,Phase 1
31 Liver Extracts Phase 3,Phase 1,Phase 2
32 Isophosphamide mustard Phase 3,Phase 2,Phase 1
33 Adjuvants, Anesthesia Phase 3
34 Analgesics Phase 3
35 Analgesics, Opioid Phase 3
36 Anesthetics Phase 3
37 Anesthetics, General Phase 3
38 Anesthetics, Intravenous Phase 3
39 Central Nervous System Depressants Phase 3
40 Narcotics Phase 3
41 pancreatic polypeptide Phase 3
42 Peripheral Nervous System Agents Phase 3,Phase 1
43 Epoetin alfa Phase 3 113427-24-0
44 Anti-Allergic Agents Phase 3
45 Antipruritics Phase 3
46 Dermatologic Agents Phase 3
47 Gastrointestinal Agents Phase 3
48 Histamine Antagonists Phase 3
49 Histamine H1 Antagonists Phase 3
50
Histamine Phosphate Phase 3 51-74-1 65513

Interventional clinical trials:

(show top 50) (show all 58)
id Name Status NCT ID Phase
1 Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors Completed NCT00002610 Phase 3
2 Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer Completed NCT00002611 Phase 3
3 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3
4 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3
5 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
6 E-MOSAIC Electronic Tool to Monitor Symptoms Completed NCT00477919 Phase 3
7 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3
8 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
9 Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients Withdrawn NCT01734863 Phase 3
10 Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney Unknown status NCT00025103 Phase 2
11 Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine Unknown status NCT00592748 Phase 1, Phase 2
12 Phase 2 Study in Patients With MiT Tumors Completed NCT00557609 Phase 2
13 A Study of R1507 in Participants With Recurrent or Refractory Sarcoma Completed NCT00642941 Phase 2
14 Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery Completed NCT01553539 Phase 2
15 Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Completed NCT00335556 Phase 2
16 Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01154452 Phase 1, Phase 2
17 High-dose ICE With Amifostine Completed NCT00003657 Phase 2
18 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2
19 Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) Completed NCT00278889 Phase 2
20 Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer Completed NCT01210222 Phase 2
21 CREATE: Cross-tumoral Phase 2 With Crizotinib Recruiting NCT01524926 Phase 2
22 Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy Recruiting NCT02968303 Phase 2
23 Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery Recruiting NCT01164228 Phase 2
24 Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma Recruiting NCT02849366 Phase 1, Phase 2
25 Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer Recruiting NCT02874430 Phase 2
26 Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Recruiting NCT01935934 Phase 2
27 Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Recruiting NCT02101775 Phase 2
28 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2
29 Vismodegib in Treating Patients With Advanced Chondrosarcomas Active, not recruiting NCT01267955 Phase 2
30 QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma Not yet recruiting NCT03132155 Phase 2
31 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Not yet recruiting NCT02867592 Phase 2
32 A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers Not yet recruiting NCT02923934 Phase 2
33 Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma Not yet recruiting NCT03116529 Phase 1, Phase 2
34 Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma Terminated NCT00072280 Phase 2
35 Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery Completed NCT01061411 Phase 1
36 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
37 Immunotoxin Therapy in Treating Patients With Advanced Cancer Completed NCT00006981 Phase 1
38 Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Completed NCT00085358 Phase 1
39 Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Recruiting NCT02390843 Phase 1
40 A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Recruiting NCT01625351 Phase 1
41 Safety Study of MGD009 in B7-H3-expressing Tumors Recruiting NCT02628535 Phase 1
42 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Recruiting NCT02020707 Phase 1
43 Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Active, not recruiting NCT00258687 Phase 1
44 Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors Active, not recruiting NCT01331135 Phase 1
45 Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Active, not recruiting NCT00989651 Phase 1
46 MT2004-30: Tomotherapy for Solid Tumors Terminated NCT00623077 Phase 1
47 Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer Unknown status NCT01295463
48 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
49 Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor Completed NCT01118078
50 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Completed NCT00253383

Search NIH Clinical Center for Clear Cell Sarcoma

Cochrane evidence based reviews: sarcoma, clear cell

Genetic Tests for Clear Cell Sarcoma

Anatomical Context for Clear Cell Sarcoma

MalaCards organs/tissues related to Clear Cell Sarcoma:

39
Kidney, Bone, Lymph Node, Lung, Tongue, Brain, Skin

Publications for Clear Cell Sarcoma

Articles related to Clear Cell Sarcoma:

(show top 50) (show all 434)
id Title Authors Year
1
Brain metastasis from gastrointestinal clear cell sarcoma. ( 27719746 )
2017
2
Primary mediastinal clear cell sarcoma: a case report and review of the literature. ( 28086809 )
2017
3
Whole-exome sequencing identifies a somatic missense mutation of NBN in clear cell sarcoma of the salivary gland. ( 27109316 )
2016
4
Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression. ( 26848979 )
2016
5
Intraperitoneal Rosai-Dorfman disease associated with clear cell sarcoma: first case report. ( 27814905 )
2016
6
Revealing the role of VEGFA in clear cell sarcoma of the kidney by protein-protein interaction network and significant pathway analysis. ( 26893674 )
2016
7
Primary pulmonary clear cell sarcoma-the first two reported cases. ( 27112339 )
2016
8
Clear cell sarcoma of the paraspinal ligament - A rare tumor at an unusual location: A review. ( 27381137 )
2016
9
Clear cell sarcoma of vulva. A case report. ( 27869448 )
2016
10
Biology and management of clear cell sarcoma: state of the art and future perspectives. ( 27253849 )
2016
11
A giant clear cell sarcoma on right scapular: A case report. ( 27452744 )
2016
12
Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney. ( 26945340 )
2016
13
Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story. ( 27000436 )
2016
14
Gastrointestinal clear cell sarcoma-like tumour of the ascending colon. ( 26890846 )
2016
15
BCOR internal tandem duplications in clear cell sarcoma of the kidney. ( 26874462 )
2016
16
BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney. ( 26493387 )
2015
17
Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney. ( 25481751 )
2015
18
Visual Diagnosis: 8-year-old Male with a Skin Mass and Inguinal Lymphadenopathy. Clear Cell Sarcoma. ( 26232472 )
2015
19
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment. ( 26286452 )
2015
20
Unusual Clinical Presentation of Gastrointestinal Clear Cell Sarcoma. ( 26675070 )
2015
21
Case of clear cell sarcoma in the left buttock in which serum neuron-specific enolase was a useful marker for monitoring disease progression. ( 25809881 )
2015
22
Clear cell sarcoma of the pancreas: a case report and review of literature. ( 25973121 )
2015
23
Clear cell sarcoma of the kidney with calcification and a novel chromosomal abnormality: a case report. ( 26182914 )
2015
24
Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. ( 26516930 )
2015
25
Clear cell sarcoma of the kidney distinguished from synovial sarcoma using genetic analysis: a case report. ( 25888919 )
2015
26
Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. ( 25556515 )
2015
27
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. ( 26573325 )
2015
28
Clear cell sarcoma of soft tissue in right parapharyngeal region: report of a rare case. ( 26617810 )
2015
29
Clear cell sarcoma-like tumor of the gastrointestinal tract: an evolving entity. ( 25724038 )
2015
30
An unusual association of malignant gastrointestinal neuroectodermal tumor (clear cell sarcoma-like) and Ewing sarcoma. ( 26163185 )
2015
31
TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney. ( 26158413 )
2015
32
Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS. ( 26337135 )
2015
33
Clear cell sarcoma of the penis: a case report. ( 26069887 )
2015
34
Biologic Activity of Autologous, Granulocyte-Macrophage Colony Stimulating Factor Secreting Alveolar Soft Parts Sarcoma and Clear Cell Sarcoma Vaccines. ( 25805798 )
2015
35
The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. ( 26542179 )
2015
36
Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. ( 26098867 )
2015
37
Novel karyotypes and cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. ( 25751590 )
2015
38
Bilateral clear cell sarcoma of the kidney. ( 25934445 )
2015
39
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report. ( 25880253 )
2015
40
Clear cell sarcoma of the kidney: Patients' characteristics and improved outcome in developing countries. ( 25175045 )
2014
41
Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS. ( 24946937 )
2014
42
Clear cell sarcoma of kidney in a neonate. ( 26023506 )
2014
43
Clear cell sarcoma of the esophagus: report of a case. ( 26183741 )
2014
44
Clear cell sarcoma. ( 25396137 )
2014
45
Clear cell sarcoma of the kidney in a child with Fanconi anemia. ( 24735155 )
2014
46
Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. ( 24937667 )
2014
47
Clear Cell Sarcoma-Like Tumor of the Gastrointestinal Tract: A Case Report and Review of the Literature. ( 25145707 )
2014
48
Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli. ( 24560887 )
2014
49
Pulmonary vein stenosis due to invasion of metastatic clear cell sarcoma. ( 25283815 )
2014
50
Clear cell sarcoma of the right lumbar region: A case report and review of the literature. ( 25202380 )
2014

Variations for Clear Cell Sarcoma

Expression for Clear Cell Sarcoma

Search GEO for disease gene expression data for Clear Cell Sarcoma.

Pathways for Clear Cell Sarcoma

GO Terms for Clear Cell Sarcoma

Biological processes related to Clear Cell Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 regulation of transcription, DNA-templated GO:0006355 9.56 ATF1 BCOR CREB1 EWSR1 FUS IGF2
2 melanocyte differentiation GO:0030318 9.16 KIT MITF
3 positive regulation of cardiac muscle tissue development GO:0055025 8.62 CREB1 ERBB3

Molecular functions related to Clear Cell Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.4 ATF1 BCOR CREB1 ERBB3 EWSR1 FUS
2 identical protein binding GO:0042802 9.35 CREB1 ERBB3 EWSR1 FUS S100B

Sources for Clear Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....